Skip to main content
Clinical Trials/NCT03357523
NCT03357523CompletedNot Applicable

Evaluation of Peripheral Microcirculation Hemodynamics Following Various Changes Based on Noninvasive Thermography: A Prospective, Randomized, Controlled Trial

Afeka, The Tel-Aviv Academic College of Engineering1 site in 1 country20 target enrollmentStarted: November 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Capillary blood flow

Study Overview

Brief Summary

The objective of the current study is to investigate the hemodynamic changes in the peripheral microcirculation system as a response to various changes, using noninvasive thermography and laser doppler

Detailed Description

This study includes a single session per subject. Microvascular and systemic variables will be monitored in response to a number of non-invasive interventions/device that are approved for clinical use and known to elicit microvascular responses. These interventions are applied consecutively, include breathing at different rates, low power visible light in the red-to-near-infrared range, increase in local temperature, and changes in the arm position.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
23 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy males and females, between 23 and 45 years of age.
  • Willing to sign informed consent

Exclusion Criteria

  • Currently smoking
  • Any abnormal skin condition in the area of light irradiation.
  • Pregnant having given birth less than 3 months ago, and/or breastfeeding.
  • Having a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
  • Having any illness that might affect the vasculature, such as diabetes (type I or II)
  • Suffering from significant concurrent illness, such as cardiac disorders or pertinent neurological disorders.
  • As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.

Outcomes

Primary Outcomes

Capillary blood flow

Time Frame: Up to 1 hour

Capillary blood flow (red blood cell velocity or flux in 'perfusion units') as measured by laser doppler (Biopac™ System, Inc, USA). This is a continuous measurement (at least 10 Hz sampling rate) from baseline to end of experiment.

Secondary Outcomes

  • Temperature distribution over hands measured by thermography(Up to 1 hour)
  • Tissue oxygenation (tcPO2)(Up to 1 hour)

Investigators

Sponsor
Afeka, The Tel-Aviv Academic College of Engineering
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials